NCT05074498 - Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of TB006 in Participants With Alzheimer's Disease | Biotech Hunter

Enrollment

154

Participants

Timeline

Start Date

October 8, 2021

Primary Completion Date

October 13, 2022

Study Completion Date

October 13, 2022

Conditions

Alzheimer's Disease

Interventions

DRUG

TB006

intravenous infusion

DRUG

Placebo

intravenous infusion

Trial Locations (18)

22031

Clinical Trial Site, Fairfax

28105

Clinical Trial Site, Matthews

30033

Clinical Trial Site, Decatur

32159

Clinical Trial Site, Lady Lake

32751

Clinical Trial Site #1, Maitland

Clinical Trial Site, Maitland

32789

Clinical Trial Site, Winter Park

32792

Clinical Trial Site, Winter Park

33126

Clinical Trial Site, Miami

33135

Clinical Trial Site, Miami

33137

Clinical Trial Site, Miami

33165

Clinical Trial Site, Miami

33407

Clinical Trial Site, West Palm Beach

33445

Clinical Trial Site, Delray Beach

34997

Clinical Trial Site, Stuart

75115

Clinical Trial Site, DeSoto

92103

Clinical Trial Site, San Diego

92845

Clinical Trial Site, Garden Grove

All Listed Sponsors

lead

TrueBinding, Inc.

INDUSTRY